Cindy Ke Zhou

Moderna Therapeutics (United States)

United States

Research Interests

Explore related searches

Professors in United States Professors in Immunology Immunology professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (10)

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Collaborators (3)

Úna Mc Menamin

Queen's University Belfast

UNITED KINGDOM

View details

Isaac Smith

Duke University

UNITED STATES

View details

Jillian Hurst

Assistant Professor

Duke University School of Medicine

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Cindy Ke Zhou

Research Interests

Explore related searches

Contact this professor

Articles (10)

Evaluation of potential adverse events following COVID-19 mRNA vaccination among adults aged 65 years and older: Two self-controlled studies in the U.S.

Development and Validation of an Algorithm for Thrombosis with Thrombocytopenia Syndrome (TTS) at Unusual Sites.

Use of Immunization Information Systems in Ascertainment of COVID-19 Vaccinations for Claims-Based Vaccine Safety and Effectiveness Studies

Characterization of COVID-19 Hospitalized Patients in Three United States Electronic Health Record Databases.

Use of Structured Electronic Health Records Data Elements for the Development of Computable Phenotypes to Identify Potential Adverse Events Associated with Intravenous Immunoglobulin Infusion.

Immune globulin usage trends in commercially insured and Medicare populations, 2009-2019.

Surveillance of COVID-19 vaccine safety among elderly persons aged 65 years and older.

Background rates of adverse events of special interest for COVID-19 vaccine safety monitoring in the United States, 2019-2020.

Testosterone therapy and cancer risks among men in the SEER-Medicare linked database.

Near real-time surveillance of safety outcomes in US COVID-19 vaccine recipients aged 12 to 64 years.

Collaborators (3)

Úna Mc Menamin

Isaac Smith

Jillian Hurst

Make your next move.